Enhancing Biomarker-Based Oncology Trial Matching Using Large Language Models
Al Khoury, N.; Shaik, M.; Wurmus, R.; Akalin, A.
Show abstract
Clinical trials are an essential component of drug development for new cancer treatments, yet the information required to determine a patients eligibility for enrollment is scattered in large amounts of unstructured text. Genomic biomarkers are especially important in precision medicine and targeted therapies, making them essential for matching patients to appropriate trials. Large language models (LLMs) offer a promising solution for extracting this information from clinical trial data, aiding both physicians and patients in identifying suitable matches. In this study, we explore various LLM strategies for extracting genetic biomarkers from oncology trials to improve patient enrollment rates. Our results show that open-source language models, when applied out-of-the-box, effectively capture complex logical expressions and structure genomic biomarkers in disjunctive normal form, outperforming closed-source models such as GPT-4 and GPT-3.5-Turbo. Furthermore, fine-tuning these open-source models with additional data significantly enhances their performance.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.